The DOI matches its Crossref record; 277 of the 277 references it cites were found in a registry or an index.
Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins?
Open accessAbstract
1. Introduction 2 2. What is the significance of the shared structural properties of disease-associated protein fibrils? 3 2.1 Mechanism of amyloid fibril formation in vitro 6 2.1.1 In vitro fibril formation involves transient population of ordered aggregates of intermediate stability, or protofibrils 6 3. Toxic properties of protofibrils 7 3.1 Protofibrils, rather than fibrils, are likely to be pathogenic 7 3.2 The toxic protofibril may be a mixture of related species 8 3.3 Morphological similarities of protofibrils suggest a common mechanism of toxicity 9 3.4 Are the amyloid diseases a subset of a much larger class of previously unrecognized protofibril diseases? 9 3.5 Fibrils, in the form of aggresomes, may function to sequester toxic protofibrils 9 4. Amyloid pores, a common structural link among protein aggregation neurodegenerative diseases 10 4.1 Mechanistic studies of amyloid fibril formation reveal common features, including pore-like protofibrils 10 4.1.1 Amyloid-β (Aβ) (Alzheimer's disease) 10 4.1.2 α-Synuclein (PD and diffuse Lewy body disease) 12 4.1.3 ABri (familial British dementia) 13 4.1.4 Superoxide dismutase-1 (amyotrophic lateral sclerosis) 13 4.1.5 Prion protein (Creutzfeldt–Jakob disease, bovine spongiform encephalopathy, etc.) 14 4.1.6 Huntingtin (Huntington's disease) 14 4.2 Amyloidogenic proteins that are not linked to disease also from pore-like protofibrils 15 4.3 Amyloid proteins form non-fibrillar aggregates that have properties of protein channels or pores 15 4.3.1 Aβ ‘channels’ 15 4.3.2 α-Synuclein ‘pores’ 16 4.3.3 PrP ‘channels’ 16 4.3.4 Polyglutamine ‘channels’ 17 4.4 Nature uses β-strand-mediated protein oligomerization to construct pore-forming toxins 17 5. Mechanisms of protofibril induced toxicity in protein aggregation diseases 19 5.1 The amyloid pore can explain the age-association and cell-type selectivity of the neurodegenerative diseases 19 5.2 Protofibrils may promote their own accumulation by inhibiting the proteasome 20 6. Testing the amyloid pore hypothesis by attempting to disprove it 21 7. Acknowledgments 22 8. References 22 Protein fibrillization is implicated in the pathogenesis of most, if not all, age-associated neurodegenerative diseases, but the mechanism(s) by which it triggers neuronal death is unknown. Reductionist in vitro studies suggest that the amyloid protofibril may be the toxic species and that it may amplify itself by inhibiting proteasome-dependent protein degradation. Although its pathogenic target has not been identified, the properties of the protofibril suggest that neurons could be killed by unregulated membrane permeabilization, possibly by a type of protofibril referred to here as the ‘amyloid pore’. The purpose of this review is to summarize the existing supportive circumstantial evidence and to stimulate further studies designed to test the validity of this hypothesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–277 of 277
The Pore-forming Toxin Proaerolysin Is Activated by Furin
Abrami, L., Fivaz, M. L., Decroly, É., Seidah, N. G., Jean, F., Thomas, G., Leppla, S. H., Buckley, J. T., & van der Goot, F. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32656 · Cited by 149
Molecular Distinction between Pathogenic and Infectious Properties of the Prion Protein
Chiesa, R., Piccardo, P., Quaglio, E., Drisaldi, B., Si-Hoe, S. L., Takao, M., Ghetti, B. F., & Harris, D. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7611-7622.2003 · Cited by 148
β-Barrel Pore-Forming Toxins: Intriguing Dimorphic Proteins
Heuck, A. P., Tweten, R. K., & Johnson, A. E. (2001) · Biochemistry · doi:10.1021/bi0155394 · Cited by 145
Sokolowski, F., Modler, A. J., Masuch, R., Zirwer, D., Baier, M., Lutsch, G., Moss, D. A., Gast, K., & Naumann, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304391200 · Cited by 145
Parkin Accumulation in Aggresomes Due to Proteasome Impairment
Junn, E., Lee, S. S., Suhr, U. T., & Mouradian, M. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203159200 · Cited by 144
A comparison of amyloid fibrillogenesis using the novel fluorescent compound K114
Crystal, A., Giasson, B. I., Crowe, A., Kung, M., Zhuang, Z., Trojanowski, J. Q., & Lee, V. M. ‐. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01949.x · Cited by 143
Ushkaryov, Y. A., Orlova, E. V., Rahman, M. A., Gowen, B., Volynski, K. E., Ashton, A. C., Manser, C., & van Heel, M. (2000) · Nature Structural Biology · doi:10.1038/71247 · Cited by 143
The alpha-synuclein mutation E46K promotes aggregation in cultured cells
Pandey, N., Schmidt, R. E., & Galvin, J. E. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.10.019 · Cited by 134
Full-length Rat Amylin Forms Fibrils Following Substitution of Single Residues from Human Amylin
Green, J., Goldsbury, C. S., Mini, T., Sunderji, S., Frey, P., Kistler, J., Cooper, G. J. S., & Aebi, U. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01377-3 · Cited by 132
Mode of action of β-barrel pore-forming toxins of the staphylococcal α-hemolysin family
Menestrina, G., Serra, M. D., & Prévost, G. (2001) · Toxicon · doi:10.1016/s0041-0101(01)00153-2 · Cited by 132
Hotze, E. M., Kubalek, E. W., Rossjohn, J., Parker, M. W., Johnson, A. E., & Tweten, R. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009865200 · Cited by 132
Mališauskas, M., Zamotin, V., Jaß, J., Noppe, W., Dobson, C. M., & Morozova‐Roche, L. A. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00551-5 · Cited by 127
Klug, G. M., Lošić, D., Supundi, Subasinghe, S., Aguilar, M., Martin, L. L., & Small, D. H. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03815.x · Cited by 124
Evidence for Early Cytotoxic Aggregates in Transgenic Mice for Human Transthyretin Leu55Pro
Sousa, M. M., Fernandes, R., Palha, J. A., Taboada, A., Vieira, P., & Saraiva, M. J. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64469-0 · Cited by 123
Aβ Protofibrils Possess a Stable Core Structure Resistant to Hydrogen Exchange
Kheterpal, I., Lashuel, H. A., Hartley, D. M., Walz, T., Lansbury, P. T., & Wetzel, R. B. (2003) · Biochemistry · doi:10.1021/bi0357816 · Cited by 122
Self-citationRay, S. S., Nowak, R. J., Strokovich, K., Brown, R. H., Walz, T., & Lansbury, P. T. (2004) · Biochemistry · doi:10.1021/bi030246r · Cited by 121
Self-citationGenetics of Parkinson's disease and biochemical studies of implicated gene products
Lansbury, P. T., & Brice, A. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00302-7 · Cited by 120
Self-citationCardoso, I., Goldsbury, C. S., Müller, S. A., et al. (2002) · Journal of Molecular Biology · doi:10.1006/jmbi.2002.5441 · Cited by 118
Age-dependent synuclein pathology following traumatic brain injury in mice
Uryu, K., Giasson, B. I., Longhi, L. G., Martínez, D., Murray, I. V. J., Conte, V., Nakamura, M., Saatman, K. E., Talbot, K., Horiguchi, T., et al. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00245-0 · Cited by 114
Holton, J. L., Ghiso, J., Lashley, T., Rostagno, A., Guerin, C. J., Gibb, G., Houlden, H., Ayling, H., Martinian, L., Anderton, B. H., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63993-4 · Cited by 114
Hirakura, Y., Carreras, I., Sipe, J. D., & Kagan, B. L. (2002) · Amyloid · doi:10.3109/13506120209072440 · Cited by 114
Assembly and Topography of the Prepore Complex in Cholesterol-dependent Cytolysins
Heuck, A. P., Tweten, R. K., & Johnson, A. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303151200 · Cited by 112
Specificity of Abnormal Assembly in Immunoglobulin Light Chain Deposition Disease and Amyloidosis
Helms, L. R., & Wetzel, R. B. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0148 · Cited by 110
Chaperones and aging: role in neurodegeneration and in other civilizational diseases
Sőti, C., & Csermely, P. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(02)00043-8 · Cited by 109
Ben‐Zvi, A., Rios, P. D. L., Dietler, G., & Goloubinoff, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405627200 · Cited by 108
Riesner, D., Kellings, K., Post, K., Wille, H., Serban, H., Groth, D., Baldwin, M. A., & Prusiner, S. B. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1714-1722.1996 · Cited by 103
Singleton, A., Myers, A., & Hardy, J. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh093 · Cited by 101
Electrophysiologic properties of channels induced by Aβ25–35 in planar lipid bilayers
Lin, M., & Kagan, B. L. (2002) · Peptides · doi:10.1016/s0196-9781(02)00057-8 · Cited by 99
Valeva, A., Palmer, M., & Bhakdi, S. (1997) · Biochemistry · doi:10.1021/bi971075r · Cited by 97
Teng, M.-H., Yin, J.-Y., Vidal, R., Ghiso, J. A., Kumar, A. R., Rabenou, R. A., Shah, A., Jacobson, D. R., Tagoe, C. E., Gallo, G., et al. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780246 · Cited by 96
Caretaker or undertaker? The role of the proteasome in aging
Gaczynska, M. E., Osmulski, P. A., & Ward, W. F. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(00)00246-3 · Cited by 94
Islet Amyloid Polypeptide in Human Insulinomas: Evidence for Intracellular Amyloidogenesis
O’Brien, T. D., Butler, A. E., Roche, P. C., Johnson, K. H., & Butler, P. C. (1994) · Diabetes · doi:10.2337/diab.43.2.329 · Cited by 94
The projection structure of Perfringolysin O (Clostridium perfringens θ‐toxin)
Olofsson, A., Hebert, H., & Thelestam, M. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80050-5 · Cited by 94
pH-Dependent Amyloid and Protofibril Formation by the ABri Peptide of Familial British Dementia
Srinivasan, R., Jones, E. M., Liu, K., Ghiso, J. A., Marchant, R. E., & Zagorski, M. G. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.09.001 · Cited by 90
Whalen, B. M., Selkoe, D. J., & Hartley, D. M. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.03.007 · Cited by 89
Poly-l-Glutamine Forms Cation Channels: Relevance to the Pathogenesis of the Polyglutamine Diseases
Monoi, H., Futaki, S., Kugimiya, S., Minakata, H., & Yoshihara, K. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76830-5 · Cited by 86
A ring-shaped structure with a crown formed by streptolysin O on the erythrocyte membrane
Sekiya, K., Satoh, R., DANBARA, H., & Futaesaku, Y. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.18.5953-5961.1993 · Cited by 85
Prion peptide fragment PrP[106-126] forms distinct cation channel types
Kourie, J. I., & Culverson, A. L. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20001001)62:1<120::aid-jnr13>3.0.co;2-2 · Cited by 85
The 118–135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion
Pillot, T., Lins, L., Goethals, M., Vanloo, B., Baert, J. H., Vandekerckhove, J. S., Rosseneu, M., & Brasseur, R. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1382 · Cited by 84
Kawahara, M., & Kuroda, Y. (2001) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007168910582 · Cited by 81
Cardoso, R. M. F., THAYER, M. M., DiDonato, M., Lo, T. P., Bruns, C. K., Getzoff, E. D., & Tainer, J. A. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01090-2 · Cited by 81
El‐Agnaf, O. M. A., Nagala, S., PATEL, B. P., & Austen, B. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4743 · Cited by 79
Small is not beautiful: antagonizing functions for the prion protein PrPC and its homologue Dpl
Behrens, A., & Aguzzi, A. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02089-0 · Cited by 78
Murine apolipoprotein serum amyloid A in solution forms a hexamer containing a central channel
Wang, L., Lashuel, H. A., Walz, T., & Colón, W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252508399 · Cited by 78
Self-citationAnnular α‐synuclein species from purified multiple system atrophy inclusions
Pountney, D. L., Lowe, R. D., Quilty, M. C., Vickers, J. C., Voelcker, N. H., & Gai, W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02533.x · Cited by 77
Imaging real-time aggregation of amyloid beta protein (1–42) by atomic force microscopy
Parbhu, A. N., Lin, H., Thimm, J. C., & Lal, R. (2002) · Peptides · doi:10.1016/s0196-9781(02)00061-x · Cited by 77
Diversity of Amyloid β Protein Fragment [1–40]-Formed Channels
Kourie, J. I., Henry, C. L., & Farrelly, P. V. (2001) · Cellular and Molecular Neurobiology · doi:10.1023/a:1010995121153 · Cited by 76
Hirakura, Y., Azimov, R., Azimova, R., & Kagan, B. L. (2000) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(20000515)60:4<490::aid-jnr7>3.0.co;2-9 · Cited by 75
Funato, H., Enya, M., Yoshimura, M., Morishima‐Kawashima, M., & Ihara, Y. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65094-8 · Cited by 73
Amyloid peptide channels: Blockade by zinc and inhibition by Congo red (amyloid channel block)
Hirakura, Y., Yiu, W. W., Yamamoto, A., & Kagan, B. L. (2000) · Amyloid · doi:10.3109/13506120009146834 · Cited by 73
Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies
Barrachina, M., Castaño, E., Dalfó, E., Maes, T., Buesa, C., & Ferrer, I. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.11.005 · Cited by 69
Sanderson, K. L., Butler, L. D., & Ingram, V. M. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01060-8 · Cited by 67
Alarcón, J. M., Brito, J. A., Hermosilla, T., Atwater, I. J., Mears, D. J., & Rojas, E. (2005) · Peptides · doi:10.1016/j.peptides.2005.07.004 · Cited by 64
Expression of Heat Shock Genes in Hepatocytes is Affected by Age and Food Restriction in Rats
Heydari, A. R., Conrad, C. C., & Richardson, A. (1995) · Journal of Nutrition · doi:10.1093/jn/125.3.410 · Cited by 61
Cholesterol Modulates Amyloid Beta-peptide’s Membrane Interactions
Eckert, G. P., Kirsch, C., Leutz, S., Wood, W. G., & Müller, W. E. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-43059 · Cited by 59
Bahadi, R., Farrelly, P. V., Kenna, B. L., Kourie, J. I., Tagliavini, F., Forloni, G., & Salmona, M. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00077.2003 · Cited by 57
Singer, S. J., & Dewji, N. N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509892103 · Cited by 57
Turner, B. J., Lopes, E. C., & Cheema, S. S. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00893-0 · Cited by 56
Pillot, T., Drouet, B., Pinçon‐Raymond, M., Vandekerckhove, J. S., Rosseneu, M., & Chambaz, J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752298.x · Cited by 51
El‐Agnaf, O. M. A., Sheridan, J. M., Sidera, C., Siligardi, G., Hussain, R., Haris, P. I., & Austen, B. (2001) · Biochemistry · doi:10.1021/bi002287i · Cited by 51
Response of C‐Reactive Protein and Serum Amyloid A to Influenza A Infection in Older Adults
Falsey, A. R., Walsh, E. E., Francis, C. W., Looney, R. J., Kolassa, J. E., Hall, W. J., & Abraham, G. N. (2001) · The Journal of Infectious Diseases · doi:10.1086/319275 · Cited by 51
Harroun, T. A., Bradshaw, J. P., & Ashley, R. H. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02972-6 · Cited by 50
The channel hypothesis of Huntington’s disease
Kagan, B. L., Hirakura, Y., Azimov, R., & Azimova, R. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00654-2 · Cited by 49
Cu/Zn superoxide dismutase can form pore-like structures
Chung, J. F., Yang, H., de Beus, M. D., Ryu, C. Y., Cho, K., & Colón, W. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.008 · Cited by 43
Human Islet Amyloid Polypeptide Accumulates at Similar Sites in Islets of Transgenic Mice and Humans
de Koning, E. J. P., Höppener, J. W. M., Verbeek, J. S., Oosterwijk, C., van Hulst, K. L., Baker, C. A., Lips, C. J. M., Morris, J. F., & Clark, A. (1994) · Diabetes · doi:10.2337/diab.43.5.640 · Cited by 42
Micelle Formation by a Fragment of Human Islet Amyloid Polypeptide
Rhoades, E. R., & Gafni, A. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)70068-x · Cited by 41
Channel activity of deamidated isoforms of prion protein fragment 106–126 in planar lipid bilayers
Kourie, J. I., Farrelly, P. V., & Henry, C. L. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1213 · Cited by 37
Copper Modulation of Ion Channels of PrP[106–126] Mutant Prion Peptide Fragments
Kourie, J. I., Kenna, B. L., Tew, D. J., Jobling, M. F., Curtain, C. C., Masters, C. L., Barnham, K. J., & Cappai, R. (2003) · The Journal of Membrane Biology · doi:10.1007/s00232-002-2005-5 · Cited by 33
Masliah, E., & Hashimoto, M. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00029-3 · Cited by 33
Assembly of the full-length recombinant mouse prion protein I. Formation of soluble oligomers
Vendrely, C., Valadié, H., Bednářová, L., Cardin, L., Pasdeloup, M., Cappadoro, J., Bednář, J., Rinaudo, M., & Jamin, M. (2005) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.05.017 · Cited by 32
Maat–Schieman, M. L. C., van Duinen, S. G., Haan, J., & Roos, R. A. C. (1992) · Acta Neuropathologica · doi:10.1007/bf00227745 · Cited by 31
Flynn, B. L., & Theesen, K. A. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.17093 · Cited by 31
Srinivasan, R., Marchant, R. E., & Zagorski, M. G. (2004) · Amyloid · doi:10.1080/13506120410001667872 · Cited by 28
Prion channel proteins and their role in vacuolation and neurodegenerative diseases
Kourie, J. I. (2002) · European Biophysics Journal · doi:10.1007/s00249-002-0242-2 · Cited by 16
Structural and functional imaging with carbon nanotube AFM probes
Hafner, J. H., Cheung, C. L., Woolley, A. T., & Lieber, C. M. (2001) · Elsevier eBooks · doi:10.1016/b978-008044031-6/50037-9 · Cited by 14
Amyloidogenesis in familial British dementia is associated with a genetic defect on chromosome 13
GHISO, J., VIDAL, R., ROSTAGNO, A., MIRAVALLE, L., HOLTON, J. L., MEAD, S., RÉVÉSZ, T., PLANT, G., & FRANGIONE, B. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06908.x · Cited by 12
(1999) · doi:10.1002/1531-8249(199912)46:6<860::aid-ana8>3.0.co;2-m
Cited by
The proteostasis network and its decline in ageing
Hipp, M. S., Kasturi, P., & Hartl, F. U. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0101-y · Cited by 1,642
Functional amyloid – from bacteria to humans
Fowler, D. M., Koulov, A. V., Balch, W. E., & Kelly, J. W. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.03.003 · Cited by 1,059
Function and structure of inherently disordered proteins
Dunker, A. K., Silman, I., Uversky, V. N., & Sussman, J. L. (2008) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2008.10.002 · Cited by 963
The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization
Hamley, I. W. (2012) · Chemical Reviews · doi:10.1021/cr3000994 · Cited by 882
Different Species of α-Synuclein Oligomers Induce Calcium Influx and Seeding
Danzer, K. M., Haasen, D., Karow, A. R., Moussaud, S., Habeck, M., Giese, A., Kretzschmar, H., Hengerer, B., & Kostka, M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2617-07.2007 · Cited by 765
Metadata
- Authors
- Lashuel, H. A., & Lansbury, P. T.
- Venue
- Quarterly Reviews of Biophysics
- Publisher
- Cambridge University Press (CUP)
- Published
- 2006-05
- Volume
- 39
- Issue
- 2
- Pages
- 167-201
- ISSN
- 0033-5835 (ISSN-L)
- 1469-8994
- OpenAlex
- W2129583700
- Cited by
- 400
- References
- 277
- FWCI
- 17.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.